LeukemiaLeukemia, Myeloid, AcuteRadiation DosageRadiation, IonizingSurvival RateCell SurvivalLeukemia, Lymphocytic, Chronic, B-CellRadiation InjuriesDose-Response Relationship, RadiationLeukemia, LymphoidLeukemia, ExperimentalRadiation ToleranceRadiationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDisease-Free SurvivalRadiation ProtectionRadiation MonitoringLeukemia Virus, MurineSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvivalLeukemia, T-CellTreatment OutcomeLeukemia, Monocytic, AcuteRadiation OncologyLeukemia, Radiation-InducedGraft SurvivalCombined Modality TherapyMoloney murine leukemia virusLeukemia, Hairy CellLeukemia L1210Time FactorsLeukemia, B-CellAntineoplastic AgentsRadiation Injuries, ExperimentalLeukemia Virus, BovineCosmic RadiationLeukemia Virus, FelineApoptosisRadiotherapyGamma RaysAntineoplastic Combined Chemotherapy ProtocolsNeoplasms, Radiation-InducedRetrospective StudiesGene Expression Regulation, LeukemicRadiation PneumonitisPrognosisRadiotherapy DosageMyeloid-Lymphoid Leukemia ProteinBackground RadiationCell Line, TumorKaplan-Meier EstimateFollow-Up StudiesRemission InductionLeukemia P388Ultraviolet RaysCytarabineNeoplasm StagingLeukemia, Biphenotypic, AcuteTumor Cells, CulturedRadiometryBone MarrowRadiation EffectsFriend murine leukemia virusHL-60 CellsAcute DiseaseCell LineRadiation-Sensitizing AgentsLeukemia-Lymphoma, Adult T-CellRadiation-Protective AgentsNeoplasm Recurrence, LocalMutationFusion Proteins, bcr-ablLeukemia, Megakaryoblastic, AcuteProportional Hazards ModelsLeukemia, Myeloid, Chronic-PhaseSignal TransductionAKR murine leukemia virusRecurrenceMolecular Sequence DataNeoplasm ProteinsPrecursor B-Cell Lymphoblastic Leukemia-LymphomaNeoplasmsAcute Radiation SyndromeDaunorubicinRadiotherapy, AdjuvantBase SequenceKaryotypingLymphomaBrain NeoplasmsBreast NeoplasmsCells, CulturedDNA DamageCell ProliferationChromosome AberrationsWhole-Body IrradiationX-RaysDose FractionationK562 CellsDrug Resistance, Neoplasm